Skip to main content
Premium Trial:

Request an Annual Quote

NIH Chemical Genomics Program Extends Simulations Plus License

NEW YORK (GenomeWeb News) – Pharmaceutical software company Simulations Plus said on Thursday that the National Institutes of Health has renewed a license agreement for the company’s cheminformatics screening platform.
 
The Lancaster, Calif.-based company said that the NIH has renewed five licenses for the company’s ClassPharmer software, which it will use in its Chemical Genomics program.
 
The licenses were originally struck in August of 2007, and have now been renewed for another year.
 
The ClassPharmer software includes data analysis features for intuitive class generation, querying and similarity screening, data visualization and filtering, and other functions.
 
Financial terms of the agreement were not released.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.